Want HARO queries in a platform?Try Connectively

Advertise Advertise

Want HARO queries in a platform?Try Connectively

Advertise

Kristi Rosa - Associate Editorial Director of OncLive at MJH Life Sciences | HARO

Home
Journalist Directory
Kristi Rosa

Kristi Rosa

Associate Editorial Director of OncLive at MJH Life Sciences

old bridge, new jersey, united states

Publications:

ccgtlive.com

ooncnursingnews.com

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Featured Articles

Adjuvant ChemoRT Yields Long-Term Survival in High-Risk Endometrial Cancer

Adjuvant ChemoRT Yields Long-Term Survival in High-Risk Endometrial Cancer Kristi Rosa Chemoradiotherapy led to OS and RFS benefit in patients with high-risk chemoradiotherapy vs radiotherapy alone. Patients with high-risk endometrial cancer experienced i... See more

oncnursingnews.com•Kristi Rosa•Jan 19, 2026

First-Line Encorafenib/Cetuximib Plus Chemo Best SOC in BRAF V600E+ mCRC

First-Line Encorafenib/Cetuximib Plus Chemo Best SOC in BRAF V600E+ mCRC Kristi Rosa Riley Kandel The frontline combination of encorafenib, cetuximab, and FOLFIRI yielded significant improvement vs SOC in BRAF V600E-mutated metastatic colorectal cancer. F... See more

oncnursingnews.com•Kristi Rosa•Jan 14, 2026

EVEREST-1 Trial in Solid Tumors Doses First Patient With A2B530

|Articles|June 4, 2023 EVEREST-1 Trial in Solid Tumors Doses First Patient With A2B530 Author(s) Kristi RosaThe autologous CAR T-cell therapy A2B530 is being investigated for solid tumors in the multicenter, first-in-human, phase 1/2 EVEREST-1 study. Adve... See more

cgtlive.com•Kristi Rosa•Dec 3, 2025

Bylined Articles

HARO Queries

Portfolio